Direct Cytopathic Effects of Particular Hepatitis B Virus Genotypes in Severe Combined Immunodeficiency Transgenic With Urokinase-Type Plasminogen Activator Mouse With Human Hepatocytes

Gastroenterology

Volumn 136, Issue 2, 2009, Pages

  Sugiyama, Masaya ^a   Tanaka, Yasuhito ^a   Kurbanov, Fuat ^a   Maruyama, Isao ^b   Shimada, Takashi ^b   Takahashi, Satoru ^a   Shirai, Tomoyuki ^a   Hino, Keisuke ^c   Sakaida, Isao ^c   Mizokami, Masashi ^a,d  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b PhoenixBio USA Corporation   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d 1 7 1 Kohnodai   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; VIRUS DNA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B VIRUS A2; HEPATITIS B VIRUS B1; HEPATITIS B VIRUS C2; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCID MOUSE; SEVERE COMBINED IMMUNODEFICIENCY; STELLATE CELL; STOP CODON; TRANSGENIC MOUSE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

EID: 58649119858     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.048     Document Type: Article

References (46)

1. Mast E.E., Alter M.J., and Margolis H.S. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 17 (1999) 1730-1733
2. Meuleman P., Libbrecht L., Wieland S., et al. Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. J Virol 80 (2006) 2797-2807
3. Sugiyama M., Tanaka Y., Sakamoto T., et al. Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G. Hepatology 45 (2007) 929-937
4. Orito E., and Mizokami M. Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology 46 (2003) 408-412
5. Pujol F.H., and Devesa M. Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepatocellular carcinoma. J Clin Gastroenterol 39 (2005) 611-618
6. Norder H., Courouce A.M., Coursaget P., et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47 (2004) 289-309
7. Kramvis A., and Kew M.C. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 12 (2005) 456-464
8. Liu C.J., Kao J.H., and Chen D.S. Therapeutic implications of hepatitis B virus genotypes. Liver Int 25 (2005) 1097-1107
9. Miyakawa Y., and Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 46 (2003) 329-338
10. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat 12 (2005) 111-124
11. Ozasa A., Tanaka Y., Orito E., et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 44 (2006) 326-334
12. Tanaka Y., Hasegawa I., Kato T., et al. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 40 (2004) 747-755
13. Tanaka Y., Mukaide M., Orito E., et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45 (2006) 646-653
14. Kremsdorf D., Soussan P., Paterlini-Brechot P., et al. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene 25 (2006) 3823-3833
15. Tong S.P., Li J.S., Vitvitski L., et al. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology 191 (1992) 237-245
16. Heckel J.L., Sandgren E.P., Degen J.L., et al. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62 (1990) 447-456
17. Rhim J.A., Sandgren E.P., Degen J.L., et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science 263 (1994) 1149-1152
18. Tateno C., Yoshizane Y., Saito N., et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165 (2004) 901-912
19. Mercer D.F., Schiller D.E., Elliott J.F., et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7 (2001) 927-933
20. Tsuge M., Hiraga N., Takaishi H., et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 42 (2005) 1046-1054
21. Sugiyama M., Tanaka Y., Kato T., et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44 (2006) 915-924
22. Yuan T.T., Sahu G.K., Whitehead W.E., et al. The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol 73 (1999) 5731-5740
23. Chua P.K., Wang R.Y., Lin M.H., et al. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79 (2005) 13483-13496
24. Harrison-Findik D.D., Schafer D., Klein E., et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 281 (2006) 22974-22982
25. Takahashi S., Hirose M., Tamano S., et al. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in paraffin-embedded sections of rat liver after carbon tetrachloride treatment. Toxicol Pathol 26 (1998) 247-252
26. Purohit V., and Brenner D.A. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 43 (2006) 872-878
27. Ramirez F., and Di Liberto M. Complex and diversified regulatory programs control the expression of vertebrate collagen genes. FASEB J 4 (1990) 1616-1623
28. Orito E., Mizokami M., Sakugawa H., et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 33 (2001) 218-223
29. Sumi H., Yokosuka O., Seki N., et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37 (2003) 19-26
30. Heijtink R.A., Paulij W., van Roosmalen M., et al. Characteristics of the early phase of chronicity in acute hepatitis B infection. J Med Virol 57 (1999) 331-336
31. Kobayashi M., Arase Y., Ikeda K., et al. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan. J Med Virol 68 (2002) 522-528
32. Lindh M., Horal P., and Norkrans G. Acute hepatitis B in Western Sweden-genotypes and transmission routes. Infection 28 (2000) 161-163
33. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13 (1995) 29-60
34. Chen C.H., Chen P.J., Chu J.S., et al. Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. Gastroenterology 107 (1994) 1514-1518
35. Lok A.S., Liang R.H., Chiu E.K., et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100 (1991) 182-188
36. Dandri M., Burda M.R., Torok E., et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33 (2001) 981-988
37. Meuleman P., Libbrecht L., De Vos R., et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41 (2005) 847-856
38. Kobayashi M., Arase Y., Ikeda K., et al. Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C. J Gastroenterol 37 (2002) 35-39
39. Murokawa H., Yoshikawa A., Ohnuma H., et al. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Vox Sang 88 (2005) 10-16
40. Liang T.J., Hasegawa K., Rimon N., et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324 (1991) 1705-1709
41. Omata M., Ehata T., Yokosuka O., et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324 (1991) 1699-1704
42. Milich D., and Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38 (2003) 1075-1086
43. Bocharov G., Ludewig B., Bertoletti A., et al. Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol 78 (2004) 2247-2254
44. Sugauchi F., Orito E., Ichida T., et al. Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology 124 (2003) 925-932
45. Sakamoto T., Tanaka Y., Simonetti J., et al. Classification of hepatitis B virus genotype B into two major types based on characterization of a novel subgenotype in the Arctic indigenous populations. J Infect Dis 196 (2007) 1487-1492
46. Mori Y., Seya T., Huang H.L., et al. Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol 76 (2002) 6750-6761